Philadelphia Pharmaceuticals Company reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was JOD 8.42 million compared to JOD 6.6 million a year ago. Net income was JOD 0.701114 million compared to JOD 0.410223 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.54 JOD | +6.21% | +6.21% | +7.69% |
1st Jan change | Capi. | |
---|---|---|
+7.69% | 16.3M | |
+24.53% | 44.76B | |
+30.99% | 23.16B | |
+24.13% | 16.02B | |
+21.15% | 14.32B | |
+68.67% | 13.7B | |
-0.05% | 6.79B | |
-13.29% | 6.47B | |
-8.87% | 5.73B | |
+13.53% | 5.65B |
- Stock Market
- Equities
- PHIL Stock
- News Philadelphia Pharmaceuticals Company
- Philadelphia Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2022